-
1061“…While type I interferons (IFNs) are universally acknowledged for their antiviral and immunostimulatory functions, there is increasing appreciation of the detrimental effects of inappropriate, excessive, or mistimed type I IFN responses in viral and bacterial infections. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1062por Génin, Pierre, Cuvelier, Frédérique, Lambin, Sandrine, Côrte-Real Filipe, Josina, Autrusseau, Elodie, Laurent, Christine, Laplantine, Emmanuel, Weil, Robert“…Viral invasion into a host is initially recognized by the innate immune system, mainly through activation of the intracellular cytosolic signaling pathway and coordinated activation of interferon regulatory factor 3 (IRF3) and nuclear factor kappa B (NF-κB) transcription factors that promote type I interferon gene induction. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1063“…The majority of indeterminate interferon (IFN)-γ release assays were due to inadequate IFN-γ response to the phytohemagglutinin. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1064“…Several treatments are currently available for relapsing-remitting multiple sclerosis. Among them, interferon (IFN) beta remains a valid treatment approach because of its good benefit/risk profile. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1065“…OBJECTIVE: Distribution of the type I interferon in different organs of the chicken digestive system. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1066por Livingstone, Mark, Sikström, Kristina, Robert, Philippe A., Uzé, Gilles, Larsson, Ola, Pellegrini, Sandra“…Type-I interferon (IFN)-induced activation of the mammalian target of rapamycin (mTOR) signaling pathway has been implicated in translational control of mRNAs encoding interferon-stimulated genes (ISGs). …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1067“…Interferons are widely used platform therapies as disease-modifying treatment of patients with multiple sclerosis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1068por Dunham, Eric C., Banadyga, Logan, Groseth, Allison, Chiramel, Abhilash I., Best, Sonja M., Ebihara, Hideki, Feldmann, Heinz, Hoenen, Thomas“…Here we investigate the relative potency of the interferon (IFN) inhibitors encoded by EBOVs from West Africa, since an important EBOV virulence factor is inhibition of the antiviral IFN response. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1069por Ji, Sang Keun, Park, Neung Hwa, Choi, Hyun Mook, Kim, Young Woo, Lee, Sin Hwa, Lee, Keum Hee, Ahn, Su Yul, Lee, Sang Uk, Han, Byung Hoon, Park, Byung ChaeEnlace del recurso
Publicado 1996
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1070por Shu, Qian, Lennemann, Nicholas J., Sarkar, Saumendra N., Sadovsky, Yoel, Coyne, Carolyn B.“…Interferon stimulated genes (ISGs) target viruses at various stages of their infectious life cycles, including at the earliest stage of viral entry. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1071por Lang Kuhs, Krystle A., Kuniholm, Mark H., Pfeiffer, Ruth M., Chen, Sabrina, Desai, Seema, Edlin, Brian R., Peters, Marion G., Plankey, Michael, Sharp, Gerald B., Strickler, Howard D., Villacres, Maria C., Quinn, Thomas C., Gange, Stephen J., Prokunina-Olsson, Ludmila, Greenblatt, Ruth M., O’Brien, Thomas R.Enlace del recurso
Publicado 2015
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1072por Correa, Andres F., Theisen, Katherine, Ferroni, Matthew, Maranchie, Jodi K., Hrebinko, Ronald, Davies, Benjamin J., Gingrich, Jeffrey R.“…Here we present a contemporary series on the effectiveness and safety of intravesical BCG plus interferon-α2B therapy in patients with BCG refractory NMIBC. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1073“…The development of direct-acting antiviral (DAA) agents that specifically target various steps in the HCV lifecycle has revolutionized therapeutic options for patients with HCV, with the development of highly effective and well-tolerated oral interferon-free regimens. There are many DAAs that are currently in development or have recently been approved, which target different nonstructural HCV proteins and host targets that are essential for HCV replication. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1074por Molnarfi, Nicolas, Prod'homme, Thomas, Schulze-Topphoff, Ulf, Spencer, Collin M., Weber, Martin S., Patarroyo, Juan C., Lalive, Patrice H., Zamvil, Scott S.“…METHODS: Monocytes were isolated from myeloid differentiation primary response gene 88 (MyD88)–deficient, Toll-IL-1 receptor domain–containing adaptor inducing interferon (IFN)–β (TRIF)–deficient, IFN-α/β receptor subunit 1 (IFNAR1)–deficient, and wild-type (WT) mice and human peripheral blood. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1075
-
1076
-
1077“…CONCLUSION: Patients with MS self-injecting interferon beta-1b expressed a high level of satisfaction and preference for BETACONNECT. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1078por Henault, Jill, Riggs, Jeffrey M., Karnell, Jodi L., Liarski, Vladimir M., Li, Jianqing, Shirinian, Lena, Xu, Linda, Casey, Kerry A., Smith, Michael A., Khatry, Deepak B., Izhak, Liat, Clarke, Lorraine, Herbst, Ronald, Ettinger, Rachel, Petri, Michelle, Clark, Marcus R., Mustelin, Tomas, Kolbeck, Roland, Sanjuan, Miguel A.“…These findings expand the known pathogenic mechanisms of IgE-mediated inflammation beyond those found in allergy and demonstrate that IgE can trigger interferon responses capable of exacerbating self-destructive autoimmune responses.…”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1079por Huang, Chun-Ta, Ruan, Sheng-Yuan, Tsai, Yi-Ju, Kuo, Ping-Hung, Ku, Shih-Chi, Lee, Pei-Lin, Kuo, Lu-Cheng, Hsu, Chia-Lin, Huang, Chun-Kai, Yang, Ching-Yao, Chien, Ying-Chun, Wang, Jann-Yuan, Yu, Chong-Jen“…Performance of interferon-gamma release assays (IGRAs) is influenced by preanalytical, laboratory and host factors. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1080por Horvati, Kata, Bősze, Szilvia, Gideon, Hannah P., Bacsa, Bernadett, Szabó, Tamás G., Goliath, Rene, Rangaka, Molebogeng X., Hudecz, Ferenc, Wilkinson, Robert J., Wilkinson, Katalin A.“…OBJECTIVES: Blood-based Interferon-Gamma Release Assays (IGRA) identify Mycobacterium tuberculosis (MTB) sensitisation with increased specificity, but sensitivity remains impaired in human immunodeficiency virus (HIV) infected persons. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto